On behalf of our CEO Eric Zudak, all of us at Thalocan Research Innovations congratulate everyone at AAD on the success of the 2026 Innovation Academy. So grateful for the conversations, the insights and learning about all of the new breakthroughs in dermatology. We’ll see you again, next year!
Innovation. That’s what we’re about, too. Tomorrow, Thalocan Research Innovations CEO Eric Zudak begins four days at AAD innovation Academy 2026 – packed with the latest breakthroughs in dermatology, cutting-edge clinical insights and meaningful networking moments. Here at TRI we share this mindset of creating and sharing innovative and state-of-the-art technologies to assist physicians, trialists…
With the release of several new and updated trainings in the coming weeks, Thalocan Research Innovations continues to establish itself as an industry leader for Investigator Training Content and Resources. Our standard and customized assessment training material is authored by globally recognized disease-specific key opinion leaders and experienced trialists. Our Creative Team enhances the content…
Looking forward to next week, when Thalocan Research Innovations CEO Eric Zudak heads to 2026 AAD Innovation Academy, a unique program packed with the latest breakthroughs in dermatology. The AAD Innovation Academy delivers cutting-edge clinical insights and meaningful networking moments. And when it comes to cutting edge, TRI is proud to deliver TRICOA, the first…
